Warning: mysql_data_seek(): Offset 0 is invalid for MySQL result index 8 (or the query data is unbuffered) in /home/domains/pharmacy-and-drugs.com/search/core.php on line 74 Pharmacy and drugs - search results: levan (2)
   
  doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: levan

6 - 10 of 22 <<previous | next>>

Articles results:

Return On Investment For Pediatric Exclusivity Program Varies Widely For Pharmaceutical Companies
The economic return for a program designed to encourage drug manufacturers to conduct more pediatric clinical trials by granting extensions of patent protection or marketing exclusivity generates lucrative returns for blockbuster products and produces more modest returns on investment for many others, according to a study in the February 7 issue of JAMA.In 1997, Congress authorized the U.S.


Applications Invited For British Pharmaceutical Conference 2007 Conference Science Medal
Applications are now being invited for the prestigious 2007 British Pharmaceutical Conference (BPC) Science Medal, the winner of which will be invited to present a lecture on his or her work at the 2008 conference. Applications are now open internationally to scientists working in a pharmaceutical or allied discipline (in industry or academia) with a proven track record of independent research, and published work that shows outstanding promise.


ADHD Drug Makers To Notify Patients About Health Risks
Makers of drugs approved to treat Attention Deficit Hyperactivity Disorder (ADHD) have been instructed by the US Food and Drug Administration (FDA) to notify patients of certain health risks.The manufacturers affected include Eli Lilly and Co, Novartis AG, Johnson & Johnson, and Shire plc.


TOP Classes Of Biologics With 2006 Sales Of US$ 63.8 Bln
The Business Intelligence firm La Merie S.L. reported today that the major cancer antibodies Rituxan, Herceptin, Avastin and Erbitux represent the no. 2 class of top selling biologics with the hightest growth rate of 57 % and combined 2006 sales of US$ 10.6 bln. In contrast, the class of erythropoietin products still had the highest sales in 2006 with US$ 11.9 bln, buth with the lowest growth rate (6.


Optimizing Clinical Trial 2007, Amsterdam, 30th - 31st May
Allan Lloyds proudly presents its upcoming "Optimizing Clinical Trial 2007" conference that will be held in Amsterdam on the 30th - 31st May 2007. This Conference is a designed platform targeting the most relevant issues, current trends, future perspectives in clinical trials within the pharmaceutical industry.




6 - 10 of 22 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.